Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies

CONCLUSIONSBrain metastases remain a common source of systemic treatment failure. The OS for patients with MBM has improved significantly. Further research into MBM prevention is needed. Cancer 2017. © 2017 American Cancer Society.

Source: Cancer - October 12, 2017 Category: Cancer & Oncology Authors: Sarah Sloot, Yian A. Chen, Xiuhua Zhao, Jamie L. Weber, Jacob J. Benedict, James J. Mul é, Keiran S. Smalley, Jeffrey S. Weber, Jonathan S. Zager, Peter A. Forsyth, Vernon K. Sondak, Geoffrey T. Gibney Tags: Original Article Source Type: research